EBERT CHARLES D 4
4 · WATSON PHARMACEUTICALS INC · Filed Mar 16, 2012
Insider Transaction Report
Form 4
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
- Tax Payment
Common Stock, par value $0.0033
2012-03-14$59.21/sh−1,265$74,901→ 26,926 total
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.